4263 — Susmed Cashflow Statement
0.000.00%
Last trade - 00:00- ¥9bn
- ¥5bn
- ¥343m
Annual cashflow statement for Susmed, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -96.6 | -276 | -233 | -49.5 | -356 |
| Depreciation | |||||
| Non-Cash Items | -63 | -55.9 | 6.22 | 12.3 | 20.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 70.5 | 96.4 | 59.6 | 132 | 98.8 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -89 | -235 | -165 | 101 | -231 |
| Capital Expenditures | -4.2 | -4.4 | -12.6 | -18.2 | -9.28 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1.63 | — | -7.75 | — | 0.749 |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.83 | -4.4 | -20.4 | -18.2 | -8.53 |
| Financing Cash Flow Items | — | — | -18.9 | 0.8 | -0.001 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | — | 1,500 | 3,463 | 62.4 | 37.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -94.8 | 1,261 | 3,277 | 145 | -202 |